Watch Senator Rosen’s full remarks aquí.
WASHINGTON, D.C. – Today, during a hearing of the Senate Committee on Health, Education, Labor and Pensions (HELP), U.S. Senator Jacky Rosa questioned Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases and National Institutes of Health, about COVID-19 testing in the U.S., and how information from testing is being utilized to combat the virus.
“As our communities focus on how to safely get back to work and school, we must follow the science and adapt to new information to ensure that we are making timely, targeted, and thoughtful decisions to protect both lives and livelihoods,” said Senator Rosen.
“Dr. Fauci, the last time you were here, we discussed monoclonal antibody treatments. As we have learned more about the virus—how it functions and how it is different from other respiratory illnesses—what updates can you tell us about the development of preventive treatments that block the virus from attaching to the cells that it’s targeting?” Senator Rosa asked Dr. Anthony Fauci.
“Out of the five types of antibodies that people are most likely to have, which ones do most recovered patients show—and does the specific antibody present make a difference if that patient could be re-infected or not, are they effectively immune, at least for some period of time?” Senator Rosa followed-up.
“We know that this virus is multi-organ – it can affect your kidneys, your lungs, your heart, your digestive system, your sense of smell—is the science of stopping the virus from causing harm the same regardless of which organ it attacks, and how do we help direct funding for the kind of research that you’re going to need to look at this multi-organ attack from this virus?” Senator Rosen’s line of questioning concluded.
###
